TC
SANA icon

T3 Companies’s Sana Biotechnology SANA Stock Holding History

T3 Companies’s Portfolio SANA Stock Details SANA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$39.4K Sell
11,300
-22,500
-67% -$72.5K 0.04% 135
2026
Q1 		$97.3K Buy
33,800
+13,800
+69% +$54.4K 0.13% 80
2025
Q4 		$81.4K Buy
+20,000
New +$89.6K 0.1% 115

Other funds holding SANA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.54B AUM 86.39% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Canada Pension Plan Investment Board
Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $181B AUM 41.77% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
MG
Marex Group London $23.6B AUM 57.16% 1-Year Est. Return

T3 Companies's SANA Position: Q2 2026 in Review

T3 Companies reduced its Sana Biotechnology (SANA) stake by 67% in Q2 2026, selling an estimated $72.5K and leaving 11,300 shares worth $39.4K. The position accounts for 0.04% of the portfolio, ranked #135.

T3 Companies first reported a position in SANA in Q4 2025 and has held it in 3 quarters since. The position peaked at $97.3K in Q1 2026. 211 funds tracked by Wall St. Rank hold SANA as of Q2 2026.

  • T3 Companies held 11,300 shares of Sana Biotechnology worth $39.4K as of Q2 2026.
  • T3 Companies sold 22,500 Sana Biotechnology shares in Q2 2026, an estimated $72.5K.
  • Sana Biotechnology made up 0.04% of T3 Companies's portfolio in Q2 2026, its #135 holding.
  • T3 Companies first reported a position in Sana Biotechnology in Q4 2025 and has held it in 3 quarters since.
  • T3 Companies's Sana Biotechnology position peaked at $97.3K in Q1 2026.
  • 211 funds tracked by Wall St. Rank held Sana Biotechnology as of Q2 2026.

Based on T3 Companies's 13F filing for Q2 2026, filed 27 Jul 2026.